Purified Serotonin Receptors for Structural Studies
用于结构研究的纯化血清素受体
基本信息
- 批准号:7233667
- 负责人:
- 金额:$ 36.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-08-01 至 2008-11-30
- 项目状态:已结题
- 来源:
- 关键词:AbattoirsAccountingAchievementAmino AcidsAntibodiesAnxietyAreaAtomic Force MicroscopyAuthorization documentationAutomobile DrivingAwardBiochemicalBioreactorsBos taurusBudgetsBusinessesC-terminalCattleCellsCollaborationsCountCrystallizationCyclic GMPDNADestinationsDetergentsDevelopmentDiseaseDisruptionDrug Delivery SystemsDrug DesignDynaminEating DisordersEndoplasmic ReticulumEnhancersEnsureEtiologyEyeFamilyFigs - dietaryFluorescenceFutureG-Protein-Coupled ReceptorsGTP-Binding ProteinsGenerationsGenesGoalsGrantGreen Fluorescent ProteinsHTR2A geneHandHeterogeneityHumanHuman GenomeHypertensionImageImageryIn VitroInvestigationIrritable Bowel SyndromeKnock-in MouseKnockout MiceKnowledgeLaboratoriesLeftLettersLigand BindingLightMarketingMechanicsMediatingMembraneMembrane ProteinsMental DepressionMental disordersMethodsMigraineModelingMolecular ConformationMusNational Institute of Mental HealthNeuronsNeurotransmittersObesityOphthalmologyPanic DisorderPathway interactionsPatternPharmaceutical PreparationsPharmacologic SubstancePhasePhotonsPhotophobiaPhotoreceptorsPhysiologicalPhysiological ProcessesPopulationPreparationPrincipal InvestigatorProcessProductionPropertyProtein Export PathwayProteinsRateReadingRegulationResearchResearch PersonnelResolutionRestRetinaRetinal DegenerationRhodopsinRiskRod Outer SegmentsRoleSalesSamplingSchizophreniaScientistSecond Messenger SystemsSecureSensorySerotoninSideSignal TransductionSiteSmall Business Funding MechanismsSmall Business Innovation Research GrantSocial PhobiaSourceSpottingsStagingStructural ModelsStructureSystemTadpolesTechnologyTestingTherapeuticTherapeutic AgentsTimeTimeLineTransgenic MiceTransgenic OrganismsTranslationsUniversitiesVisual system structureVomitingWashingtonWorkX-Ray CrystallographyXenopusXenopus laevisXenopus oocyteabsorptionbasecommercializationdensitydesigndesiredimerdisease-causing mutationdrug discoveryextracellulargenetic manipulationglycosylationhuman CCXCR1 receptorimprovedin vivointerestmilligrammolecular modelingnovelpolypeptidepreventprofessorprogramspromoterprotein functionprotein misfoldingprotein structurereceptorreceptor expressionretinal rodsrhorod outer segment discscale upsecond messengerserotonin receptorsuccessthree dimensional structuretool
项目摘要
DESCRIPTION (provided by applicant): Serotonin (5-HT) is a neurotransmitter that has been implicated in the aetiology of numerous Mental Health disorders, including depression, anxiety, social phobia, schizophrenia, obsessive-compulsive and panic disorders, migraine, and eating disorders. There are 12 5-HT receptor subtypes with similar recognition properties yet widely divergent physiological roles that belong to the same family of G Protein Coupled Receptors (GPCRs), hindering the discovery of subtype-selective drugs. Knowledge of the 3-dimensional structure of these receptors would enable the design of selective drugs. However, solving the structure at atomic resolution of membrane proteins such as GPCRs has been hampered by the difficulty to purify sufficient amounts of homogeneous and functional protein. Here, it is proposed a novel, proprietary expression system combined with a purification method to generate large amounts of high quality purified receptor, which could solve the bottleneck for structural elucidation of these important drug targets. Our goal is to generate large amounts of purified homogenous receptor sample for each one of the 12 human 5-HT receptor subtypes. This high quality purified material will be a highly valuable product enabling structural elucidation of these receptors.
描述(由申请人提供):血清素 (5-HT) 是一种神经递质,与多种精神健康疾病的病因有关,包括抑郁症、焦虑症、社交恐惧症、精神分裂症、强迫症和恐慌症、偏头痛和饮食失调。属于同一G蛋白偶联受体(GPCR)家族的12种5-HT受体亚型具有相似的识别特性,但生理作用却截然不同,这阻碍了亚型选择性药物的发现。了解这些受体的三维结构将使选择性药物的设计成为可能。然而,由于难以纯化足够量的同质和功能性蛋白质,以原子分辨率解析 GPCR 等膜蛋白的结构受到了阻碍。在这里,我们提出了一种新颖的、专有的表达系统与纯化方法相结合,以产生大量高质量的纯化受体,这可以解决这些重要药物靶点结构解析的瓶颈。我们的目标是为 12 种人类 5-HT 受体亚型中的每一种产生大量纯化的均质受体样本。这种高质量的纯化材料将是一种非常有价值的产品,能够阐明这些受体的结构。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David Salom其他文献
David Salom的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David Salom', 18)}}的其他基金
Crystallization of the human cannabinoid type 2 receptor
人大麻素 2 型受体的结晶
- 批准号:
7334506 - 财政年份:2003
- 资助金额:
$ 36.59万 - 项目类别:
Crystallization of the human cannabinoid type 2 receptor
人大麻素 2 型受体的结晶
- 批准号:
7406679 - 财政年份:2003
- 资助金额:
$ 36.59万 - 项目类别:
Crystallization of the human cannabinoid type 2 receptor
人大麻素 2 型受体的结晶
- 批准号:
7052999 - 财政年份:2003
- 资助金额:
$ 36.59万 - 项目类别:
Crystallization of the human cannabinoid type 2 receptor
人大麻素 2 型受体的结晶
- 批准号:
7166080 - 财政年份:2003
- 资助金额:
$ 36.59万 - 项目类别:
Purified Serotonin Receptors for Structural Studies
用于结构研究的纯化血清素受体
- 批准号:
6690933 - 财政年份:2003
- 资助金额:
$ 36.59万 - 项目类别:
相似国自然基金
套期会计有效性的研究:实证检验及影响机制
- 批准号:72302225
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
上市公司所得税会计信息公开披露的经济后果研究——基于“会计利润与所得税费用调整过程”披露的检验
- 批准号:72372025
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
全生命周期视域的会计师事务所分所一体化治理与审计风险控制研究
- 批准号:72372064
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
兔死狐悲——会计师事务所同侪CPA死亡的审计经济后果研究
- 批准号:72302197
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
环境治理目标下的公司财务、会计和审计行为研究
- 批准号:72332003
- 批准年份:2023
- 资助金额:166 万元
- 项目类别:重点项目
相似海外基金
Development of Patient-Tailored Adaptive Treatment Strategies for Acute Severe Ulcerative Colitis
制定针对急性重症溃疡性结肠炎的患者定制适应性治疗策略
- 批准号:
10569397 - 财政年份:2023
- 资助金额:
$ 36.59万 - 项目类别:
An Integrated Data Approach to Exploring Racial Differences in Reading Intervention Effectiveness
探索阅读干预效果中种族差异的综合数据方法
- 批准号:
10567796 - 财政年份:2023
- 资助金额:
$ 36.59万 - 项目类别:
Clinical and Molecular based prognostic factors for Venous Thromboembolism (VTE) in Children with Sickle Cell Disease
镰状细胞病儿童静脉血栓栓塞 (VTE) 的临床和分子预后因素
- 批准号:
10739524 - 财政年份:2023
- 资助金额:
$ 36.59万 - 项目类别: